Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Reform Bill Introduced Dec. 20 By Reps. Greenwood, Eshoo

This article was originally published in The Gray Sheet

Executive Summary

Device-related FDA reform legislation will be pending in the House when the 107th Congress returns for its second legislative session in January

You may also be interested in...



House Loses Medical Device Reform Architect To BIO

Rep. Jim Greenwood's (R-Penn.) experience drafting combination product legislation suggests BIO will be alert to shared opportunities in the biologics/device policy arena

House Loses Medical Device Reform Architect To BIO

Rep. Jim Greenwood's (R-Penn.) experience drafting combination product legislation suggests BIO will be alert to shared opportunities in the biologics/device policy arena

MDUFMA Addresses In Vitro Diagnostics, Combination Product Regulation

FDA will be required to report to Congress on Center for Biologics Evaluation & Research review times for in vitro diagnostics under the "Medical Device User Fee and Modernization Act" of 2002 (MDUFMA), which cleared the House Energy & Commerce Committee Oct. 2

Related Content

UsernamePublicRestriction

Register

MT015869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel